Clinical Trials in Coorparoo, Australia
2 recruiting
Showing 1–10 of 10 trials
Recruiting
Phase 3
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
ObesityWeight Gain
Eli Lilly and Company300 enrolled75 locationsNCT06439277
Recruiting
The Australian HCV Point-of-Care Testing Program
Hepatitis C
Kirby Institute60,000 enrolled69 locationsNCT05042544
Recruiting
Phase 2
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
ObesityDiabetes Mellitus, Type 2Overweight
Eli Lilly and Company200 enrolled38 locationsNCT07215559
Recruiting
Phase 1
Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients
Moderate-to-severe Atopic Dermatitis
TRex Bio, Inc.115 enrolled14 locationsNCT06934252
Recruiting
Phase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
AbbVie1,500 enrolled267 locationsNCT06012240
Recruiting
Phase 1
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Alopecia AreataVitiligo
Dren Bio80 enrolled20 locationsNCT06602232
Recruiting
Phase 1
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo
Vitiligo
Forte Biosciences, Inc.64 enrolled6 locationsNCT06905873
Recruiting
Phase 1
A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Alopecia Areata
Forte Biosciences, Inc.32 enrolled6 locationsNCT07205159
Recruiting
Phase 2
A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis
Plaque Psoriasis
Zai Lab (Hong Kong), Ltd.250 enrolled10 locationsNCT06380907
Recruiting
The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Hepatitis C
Kirby Institute40,000 enrolled11 locationsNCT05248555